Prakhar Khanna is a Writer at CNET with bylines in ZDNET, Forbes, and other major outlets. A digital nomad at heart, he thrives in chaos--mixing deadlines with travel, often writing stories on planes, ...
Infinix is baking a fresh batch of smartphones. Shortly after the GT 50 Pro surfaced on the web, the Infinix Note 60 Ultra has also leaked in full, revealing everything from its design to its core ...
The Zettlab D6 Ultra is definitely a work-in-progress. The ZettOS platform seems solid, and could be developed into something like UGOS Pro in short order. However, the asking price is too high, and ...
This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Not all tech deals are bargains. Confused? There’s a ...
The Samsung Galaxy S26 Ultra is poised to make a significant impact in the smartphone industry with its innovative features and hardware. As the flagship model of the Galaxy S26 series, this device is ...
Brendan Carr, the Trump-appointed chair of the FCC, wants TV broadcasters to rally around the American flag in celebration of the U.S.’s 250th anniversary this year — suggesting that, for example, ...
Build Glass front (Poco Shield Glass), aluminum alloy frame, fiber-reinforced plastic back or silicone polymer back Glass front (Gorilla Glass 7i), aluminum frame, glass back SIM · Nano-SIM + Nano-SIM ...
BeyondTrust warns of critical RCE flaw CVE-2026-1731 in RS and PRA Vulnerability allows unauthenticated OS command execution, risking compromise and data exfiltration Patch released February 2, 2026; ...
An Ionis Pharmaceuticals drug in development for Angelman syndrome has mid-stage clinical trial results showing improvement across a range of measures of this rare neurodevelopmental disorder, and the ...
2026 catalysts include two potential approvals and expected pivotal Phase 3 data from the GTX-102 Phase 3 Aspire study for Angelman syndrome NOVATO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- ...
2025 total revenue of $673 million, Crysvita ® revenue of $481 million and Dojolvi ® revenue of $96 million 2026 total revenue from current products expected to be between $730 million to $760 million ...
Learn everything you need to know about ProShares UltraPro Dow30 (UDOW) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the right ...